ArticleSleep medicine2026
Performance of obstructive sleep apnea screening questionnaires in hospitalized patients with heart failure.
Article in Sleep medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposePrevalence of obstructive sleep apnea (OSA) in patients with heart failure (HF) is estimated at 40-50%. Screening questionnaires such as the STOP-BANG, Berlin Questionnaire (BQ) and Epworth Sleepiness Scale (ESS) have guided clinical decision making in the general population. Performance of these screening tools in hospitalized patients with HF is not known.
methodsHospitalized patients with HF who were not already diagnosed with OSA underwent inpatient sleep testing and completed questionnaires, during the admissions. Performance of the Berlin Questionnaire (BQ), The Epworth Sleepiness Scale (ESS), and the STOP-BAG questionnaire was measured against the inpatient cardiorespiratory test as the reference standard.
resultsA total of 358 hospitalized HF patients completed all questionnaires and sleep testing. Among them, 215 were diagnosed with OSA. For the prediction of OSA, a model that used weight, age, sex, and cardiovascular parameters including atrial fibrillation, hypertension, left-ventricular dimension, and ejection fraction performed moderately (AUC: 0.688 (95% CI 0.617-0.759)). The addition of any or all of the commonly used questionnaires (STOP-BAG, the BQ, or the ESS) to any demographic or cardiovascular parameters-based model could not exceed the performance of the combined demographic and cardiovascular parameter model in predicting OSA.
conclusionOSA screening instruments including STOP-BAG, BQ, and ESS may perform adequately in the general population, but they demonstrated poor performance for predicting OSA in hospitalized HF patients. An approach to surveillance for SDB in hospitalized patients with HF should not rely solely on symptoms-based screening instruments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.